World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
No Access

Protective Provisions in Biotech Strategic Alliances

    https://doi.org/10.1142/S0219030304000874Cited by:0 (Source: Crossref)
    Previous
    Next

    Abstract

    The article is about the protective provision in Biotech Strategic Alliances. It is written by three associates/partners at Morgan Lewis. The article is about the strategic partnership between companies and how large and small companies can structure an alliance to protect their investments as well as progress their collaboration.